IQG Company Removed from Official List - Failure to pay Annual Listing Fee - 2022/2023 - Delisted 19th of September 2022 (Price Sensitive) |
19/09/22 | PRICE SENSITIVE | 199.99KB | Share |
|
IQG Continued Suspensison - Failure to lodge Preliminary Final Report for 30 June 2022 (Price Sensitive) |
14/09/22 | PRICE SENSITIVE | 174.74KB | Share |
|
IQG Continued Suspension - Non-payment of Annual Listing Fee 2022-2023 (Price Sensitive) |
15/08/22 | PRICE SENSITIVE | 177.3KB | Share |
|
IQG Execution Of Deed Of Company Arrangement (Price Sensitive) |
05/08/22 | PRICE SENSITIVE | 102.51KB | Share |
|
IQG Outcome Of Creditors' Meeting (Price Sensitive) |
01/08/22 | PRICE SENSITIVE | 153.28KB | Share |
|
IQG Deferral Financial Reporting Obligations (Price Sensitive) |
17/05/22 | PRICE SENSITIVE | 262.78KB | Share |
|
IQG Continued Suspension - Failure to lodge Half Yearly Financial Statements- 31 December 2021 (Price Sensitive) |
17/03/22 | PRICE SENSITIVE | 428.48KB | Share |
|
IQG The phone number for the VA has now been corrected (Price Sensitive) |
16/03/22 | PRICE SENSITIVE | 136.47KB | Share |
|
IQG iQG Seeks Voluntary Admin Today to Restructure (Price Sensitive) |
11/03/22 | PRICE SENSITIVE | 125.95KB | Share |
|
IQG Worldwide license for Harvard Uni’s eRapid Technology (Price Sensitive) |
07/03/22 | PRICE SENSITIVE | 302.2KB | Share |
|
IQG Appointment/Resignation of Company Secretary |
13/12/21 | | 256.09KB | Share |
|
IQG FDA Breakthrough Devices Designation (Price Sensitive) |
13/12/21 | PRICE SENSITIVE | 283.71KB | Share |
|
IQG IQG Results of AGM FY2021 |
19/11/21 | | 44.39KB | Share |
|
IQG IQG Chairman's Address |
18/11/21 | | 565.03KB | Share |
|
IQG Wyss Validation Study SARS-CoV-2 (Price Sensitive) |
11/11/21 | PRICE SENSITIVE | 296.79KB | Share |
|
IQG OncoTEX Gold Compound Licensing (Price Sensitive) |
05/11/21 | PRICE SENSITIVE | 314.5KB | Share |
|
IQG Jobkeeper s323DB Notice |
02/11/21 | | 34.32KB | Share |
|
IQG Notice of Annual General Meeting & Proxy Form |
20/10/21 | | 674.33KB | Share |
|
IQG LSBD Update on Biosensor FDA Pre-Submission (Price Sensitive) |
19/10/21 | PRICE SENSITIVE | 353.13KB | Share |
|
IQG Additional Annual Report Disclosure (Price Sensitive) |
06/10/21 | PRICE SENSITIVE | 562.15KB | Share |
|
IQG Director's Declaration - Peter Mercouris |
27/09/21 | | 105.13KB | Share |
|
IQG Annual Report 2021 (Price Sensitive) |
13/09/21 | PRICE SENSITIVE | 577.39KB | Share |
|
IQG Annual Nominated Adviser Statement - 2021-2022 |
23/08/21 | | 183.22KB | Share |
|
IQG Portfolio Company Awarded $6.3M Federal Govt Grant (Price Sensitive) |
09/07/21 | PRICE SENSITIVE | 112.77KB | Share |
|
IQG Appointment / Resignation of Company Secretary |
04/05/21 | | 110.04KB | Share |
|
IQG Progress of clinical programs |
29/04/21 | | 227.51KB | Share |
|
IQG Proceedings brought against ADS Capital Pty Ltd (Price Sensitive) |
08/04/21 | PRICE SENSITIVE | 487.01KB | Share |
|
IQG Appointment of Director Peter Mercouris |
22/03/21 | | 174.19KB | Share |
|
IQG Directors Initial Interests Peter Mercouris |
22/03/21 | | 233.18KB | Share |
|
IQG iQG Limited Half-yearly Financial Report (Price Sensitive) |
12/03/21 | PRICE SENSITIVE | 614.74KB | Share |
|
IQG Form 604 Con Tsigounis |
22/02/21 | | 173.16KB | Share |
|
IQG Form 604 George Syrmalis |
22/02/21 | | 183.24KB | Share |
|
IQG Change of Director’s Interest Con Tsigounis |
22/02/21 | | 235.5KB | Share |
|
IQG Change of Director’s Interest George Syrmalis |
22/02/21 | | 179.63KB | Share |
|
IQG Disregard Change of Directors Interest |
08/02/21 | | 84.11KB | Share |
|
IQG iQG Employee Share Plan Issue |
08/02/21 | | 320.61KB | Share |
|
IQG Change of Director’s Interest George Syrmalis |
05/02/21 | | 178.8KB | Share |
|
IQG iQG Change of Auditor |
01/02/21 | | 88.2KB | Share |
|
IQG iQG Limited Results of AGM |
29/01/21 | | 126.12KB | Share |
|
IQG iQG Chairmans Address |
28/01/21 | | 288.38KB | Share |
|
IQG iQG Limited Appointment/Resignation of CoSec |
12/01/21 | | 170.32KB | Share |
|
IQG Price Query (Price Sensitive) |
12/01/21 | PRICE SENSITIVE | 164.48KB | Share |
|
IQG Response to NSX Price Query (Price Sensitive) |
12/01/21 | PRICE SENSITIVE | 312.74KB | Share |
|
IQG Notice of Annual General Meeting & Proxy Form |
24/12/20 | | 603.52KB | Share |
|
IQG Removal of Trading Halt |
02/12/20 | | 143.26KB | Share |
|
IQG Request Trading Halt (Price Sensitive) |
01/12/20 | PRICE SENSITIVE | 525.49KB | Share |
|
IQG Postponement of Annual General Meeting |
25/11/20 | | 555.71KB | Share |
|
IQG Media Report (Price Sensitive) |
23/11/20 | PRICE SENSITIVE | 390.3KB | Share |
|
IQG Response to Periodic Disclosure Query (Price Sensitive) |
05/11/20 | PRICE SENSITIVE | 427.9KB | Share |
|
IQG Periodic Disclosure Query (Price Sensitive) |
05/11/20 | PRICE SENSITIVE | 422.32KB | Share |
|
IQG Notice of Annual General Meeting & Proxy Form |
26/10/20 | | 810.8KB | Share |
|
IQG Annual Report to the Shareholders (Price Sensitive) |
26/10/20 | PRICE SENSITIVE | 2.66MB | Share |
|
IQG Annual Report 2020 (Price Sensitive) |
12/09/20 | PRICE SENSITIVE | 1.1MB | Share |
|
IQG Change in Auditor Entity |
22/07/20 | | 897.33KB | Share |
|
IQG COVID-19 Diagnostic Test With Harvard University (Price Sensitive) |
29/05/20 | PRICE SENSITIVE | 381.19KB | Share |
|
IQG FDA Engagement Commences for Saliva Glucose Biosensor (Price Sensitive) |
05/05/20 | PRICE SENSITIVE | 381.76KB | Share |
|
IQG IQN Half Yearly Report 31 December 2019 (Price Sensitive) |
16/03/20 | PRICE SENSITIVE | 1.41MB | Share |